Hutch News

Hutch News

Stories tagged 'Brian Till'

Good News at Fred Hutch

Celebrating faculty and staff achievements

Sept. 14, 2017

An immunotherapy technology developed by Dr. Brian Till with Dr. Oliver Press at Fred Hutchinson Cancer Research Center has been licensed by Mustang Bio Inc., a subsidiary of the biopharmaceutical company Fortress Biotech Inc. The exclusive, worldwide license, announced Sept. 14 by Mustang Bio, will allow a new type of CAR (chimeric antigen receptor) T-cell therapy to be tested in a clinical trial as a treatment for B-cell non-Hodgkin lymphomas. The novel immunotherapy targets CD20, a protein marker on cancer cells in lymphoma.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

June 3, 2016

Dr. Marian Neuhouser takes office as president of the American Society for Nutrition; study by Drs. Harmit Malik and Matthew Daugherty IDs key difference between mouse and human immune systems and points to novel human defense against viruses; HICOR researchers Drs. Josh Roth, Aasthaa Bansal honored for new study abstracts; and eight Fred Hutch/UW Cancer Consortium researchers awarded pilot grants.

View story >



GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.